Form 8.3 - WILLIS TOWERS WATSON PLC

LONDON--(BUSINESS WIRE)-- 

Ap19

FORM 8.3

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

1. KEY INFORMATION

Name of person dealing (Note 1)	Barclays PLC.
Company dealt in	WILLIS TOWERS WATSON PLC
Class of relevant security to which the	ORD
dealings being disclosed relate (Note 2)
Date of dealing	08 October 2020

2. INTERESTS AND SHORT POSITIONS

(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)

Class of relevant security:		ORD
		Long		Short
		Number	(%)	Number	(%)
(1)	Relevant securities
		2,494,561	1.94%	465,044	0.36%
(2)	Derivatives (other than options):
		355,000	0.28%	388,524	0.30%
(3)	Options and agreements to
	purchase/sell:	0	0.00%	0	0.00%
	TOTAL:
		2,849,561	2.21%	853,568	0.66%

(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)

Class of relevant security:	Long		Short
	Number	(%)	Number	(%)
(1) Relevant securities
(2) Derivatives (other than options)
(3) Options and agreements to purchase/sell
Total

Ap20

1. DEALINGS (Note 4)

(a) Purchases and sales

Purchase/sale	Number of relevant securities	Price per unit
Purchase	2	212.5950 USD
Purchase	30	211.1800 USD
Purchase	39	211.8500 USD
Purchase	87	213.0185 USD
Purchase	100	213.4200 USD
Purchase	113	212.9255 USD
Purchase	137	212.4100 USD
Purchase	194	213.2795 USD
Purchase	328	214.0316 USD
Purchase	377	212.2561 USD
Purchase	400	213.8934 USD
Purchase	469	212.4830 USD
Purchase	755	212.9188 USD
Purchase	991	212.5037 USD
Purchase	1,001	212.3989 USD
Purchase	2,323	211.0700 USD
Purchase	2,392	211.0940 USD
Purchase	2,470	213.3929 USD
Purchase	2,912	212.9866 USD
Purchase	3,315	212.1284 USD
Purchase	4,783	211.6721 USD
Purchase	5,709	212.3370 USD
Purchase	6,513	212.6153 USD
Purchase	6,825	213.1856 USD
Purchase	7,285	212.2352 USD
Purchase	8,726	211.7620 USD
Purchase	20,140	212.4511 USD
Sale	4	212.8900 USD
Sale	4	212.6337 USD
Sale	25	211.3500 USD
Sale	39	211.8500 USD
Sale	92	212.9000 USD
Sale	100	212.7100 USD
Sale	200	213.9167 USD
Sale	200	211.4000 USD
Sale	200	213.8700 USD
Sale	200	213.0925 USD
Sale	200	211.9250 USD
Sale	284	211.6407 USD
Sale	354	211.3815 USD
Sale	377	212.3383 USD
Sale	435	211.3667 USD
Sale	809	213.7983 USD
Sale	904	211.0387 USD
Sale	2,323	211.0700 USD
Sale	3,438	211.1551 USD
Sale	4,140	212.6633 USD
Sale	4,490	213.4660 USD
Sale	4,513	213.0299 USD
Sale	4,700	212.0182 USD
Sale	5,130	211.0849 USD
Sale	5,368	212.3337 USD
Sale	39,887	212.5101 USD

(b) Derivatives transactions (other than options transactions)

Product name, e.g. CFD

Nature of transaction (Note 6)

Number of relevant securities (Note 7)

Price per unit (Note 5)

(c) Options transactions in respect of existing relevant securities

(i) Writing, selling, purchasing or varying

Product name, e.g. call option

Writing, selling, purchasing, varying etc.

Number of securities to which the option relates (Note 7)

Exercise price

Type, e.g. American, European etc.

Expiry date

Option money paid/received per unit (Note 5)

(ii) Exercising

Product name, e.g. call option

Number of securities

Exercise price per unit (Note 5)

(d) Other dealings (including transactions in respect of new securities) (Note 4)

Nature of transaction (Note 8)

Details

Price per unit (if applicable) (Note 5)

Ap21

2. OTHER INFORMATION

Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing

and any other person relating to the voting rights of any relevant securities under any option

referred to on this form or relating to the voting rights or future acquisition or disposal of any

relevant securities to which any derivative referred to on this form is referenced. If none, this

should be stated.

NONE

Is a Supplemental Form 8 (Open Positions) attached?	NO
Date of disclosure:	9 Oct 2020
Contact name:	Large Holdings Regulatory Operations
Telephone number:	020 3134 7213
If a connected EFM, name of offeree/offeror with which connected
If a connected EFM, state nature of connection